Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk.
Journal: The American journal of gastroenterology
Published: January 26, 2026
Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease.
Journal: Crohn's & colitis 360
Published: July 22, 2025
Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 09, 2025
Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.
Journal: Digestive diseases and sciences
Published: October 05, 2024
Showing 1-4 of 4
Last Updated: 09/26/2026